Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.050 | 1.050 | 0.000 |
Stocks | 98.950 | 98.950 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 26.519 | 16.758 |
Price to Book | 8.162 | 2.646 |
Price to Sales | 4.826 | 1.966 |
Price to Cash Flow | 21.620 | 10.194 |
Dividend Yield | 1.042 | 2.800 |
5 Years Earnings Growth | 12.170 | 12.026 |
Name | Net % | Category Average |
---|---|---|
Technology | 37.960 | 19.994 |
Healthcare | 19.480 | 13.966 |
Industrials | 11.750 | 13.786 |
Financial Services | 10.670 | 18.289 |
Communication Services | 7.310 | 8.263 |
Consumer Cyclical | 6.590 | 12.361 |
Consumer Defensive | 5.220 | 9.239 |
Basic Materials | 1.020 | 9.763 |
Number of long holdings: 64
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 6.06 | 428.25 | +0.68% | |
NVIDIA | US67066G1040 | 5.76 | 936.67 | -1.17% | |
Alphabet A | US02079K3059 | 4.69 | 177.56 | +0.36% | |
Apple | US0378331005 | 4.35 | 192.48 | +0.75% | |
Visa A | US92826C8394 | 3.84 | 276.07 | -0.89% | |
Novo Nordisk B | DK0062498333 | 3.45 | 924.3 | +2.32% | |
UnitedHealth | US91324P1021 | 3.18 | 519.93 | +0.52% | |
ASML Holding | NL0010273215 | 2.60 | 849.90 | -1.71% | |
Meta Platforms | US30303M1027 | 2.54 | 466.86 | -0.42% | |
Broadcom | US11135F1012 | 2.53 | 1,398.92 | -1.07% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU0912194254 | 2.65B | 6.30 | 4.68 | 9.01 | ||
LU0912192399 | 2.65B | 6.11 | 4.15 | 8.46 | ||
LU1069836580 | 1.74B | 5.11 | 8.52 | - | ||
LU0912202297 | 1.74B | 5.08 | 8.41 | - | ||
LU0912199139 | 1.74B | 4.85 | 7.71 | 6.61 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review